Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
University of Wisconsin, Madison Nephro-Tech 1, LLC |
---|---|
Information provided by: | University of Wisconsin, Madison |
ClinicalTrials.gov Identifier: | NCT00204893 |
This is a Phase I, single center, open-label study of the dietary supplement calcium formate in normal, healthy female subjects. The purpose of the study is to determine whether daily use of calcium formate is safe and whether it accumulates in the eye.
Condition | Intervention | Phase |
---|---|---|
Healthy |
Drug: calcium formate |
Phase I |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Uncontrolled, Single Group Assignment |
Official Title: | Evaluation of the Ocular Safety of Calcium Formate in Normal, Healthy Female Subjects |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Wisconsin | |
University of Wisconsin Hospital and Clinics | |
Madison, Wisconsin, United States, 53792 |
Principal Investigator: | Michael M Altaweel, MD | University of Wisconsin, Madison |
Study ID Numbers: | 2003-297 |
Study First Received: | September 12, 2005 |
Last Updated: | October 31, 2008 |
ClinicalTrials.gov Identifier: | NCT00204893 |
Health Authority: | United States: Institutional Review Board |
Calcium, Dietary Healthy |